… with prostate cancer is a … metastatic disease, which continues to be associated with a high
rate of death despite multiple new-drug approvals in recent years. Metastatic prostate cancer …

… outcomes, metastatic prostate cancer is currently … of metastatic prostate cancer with ten
new drugs approved in the United States for metastatic castration resistant prostate cancer (…

… To characterize the subclonal architecture of androgen-deprived metastatic prostate cancer,
… metastases from different anatomic sites in each patient and, in five cases, the prostate …

… prostate cancer; CRPC, castration-resistant prostate cancer; mCRPC, metastatic
castrationresistant prostate cancer. Bold … approaches in metastatic hormone-sensitive prostate …

… metastatic castration-resistant prostate cancer in whom the disease has progressed after
chemotherapy. New treatment options are needed for patients with metastatic prostate cancer …

… metastatic castration-resistant prostate cancer from limited bone involvement (left) to progressive
bone metastases (middle) to extensive metastases (… and liver) metastases. Green boxes …

… median overall survival and cancer-specific survival were 43 mo and 61 mo for LN metastases,
24 mo and 32 mo for bone metastases, 16 mo and 26 mo for visceral metastases, and 14 …

… in men with metastatic, hormone-sensitive prostate cancer. The … in men with high-volume
metastatic disease, 7 are substantially … prostate cancer, regardless of the burden of metastatic …

… stage prostate-specific membrane antigen–positive metastatic castration-resistant prostate
cancer… improve survival outcomes of men with metastatic prostate cancer in the coming years. …

… registry from 2004 through 2013, we sought to analyze the temporal relationship between
relaxed screening and increases in yearly incidence of advanced or metastatic prostate cancer…